ArticleClinical and translational science2024
Patient, industry, and regulatory perspective on antibody-drug conjugates dose optimization.
Salaheldin Hamed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it